World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 22 June 2020
Main ID:  ISRCTN88318437
Date of registration: 31/10/2017
Prospective Registration: No
Primary sponsor: Fondecyt
Public title: Evaluation of the relationship between maximal aerobic capacity and metabolic flexibility in response to fasting glucose/insulin in humans (Evaluación de la relación entre la capacidad aeróbica máxima y flexibilidad metabólica en respuesta a ayuno prolongado e infusión de glucosa/insulina en humanos)
Scientific title: Evaluation of the relationship between maximal aerobic capacity and metabolic flexibility in response to fasting glucose/insulin in humans
Date of first enrolment: 12/09/2017
Target sample size: 20
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN88318437
Study type:  Interventional
Study design:  Interventional single-center randomized crossover trial (Other)  
Phase:  Not Applicable
Countries of recruitment
Chile
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Jose    Galgani Fuentes
Address:  Avda. Libertador Bernardo OHiggins 340 8320000 Santiago Chile
Telephone: +56 (0)2 354 6389
Email: jgalgani@uc.cl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Healthy men (by physical examination, past and current medical history, and routine blood testing, including biochemical profile, thyroid-stimulating hormone, free thyroxine, electrolytes, creatinine, and hemogram)
2. Between 18 and 35 years old
3. IMC: 18.5 – 25 kg/m2
4. Stable body weight (change<2 kg over the past 3 months)
5. Physical activity (<3 days/week)
6. Do not take medications

Exclusion criteria:
1. Men with any disease
2. Younger than 18 years old and older than 35 years old
3. Unstable weight (change>2 kg over the past 3 months)
4. Physical activity (>3 days/wk)
5. Taking medications


Age minimum:
Age maximum:
Gender: Male
Health Condition(s) or Problem(s) studied
Metabolic flexibility and maximal aerobic capacity in healthy subjects
Nutritional, Metabolic, Endocrine
Intervention(s)

In the selected individuals, the maximum aerobic capacity (by indirect calorimetry) and lactate threshold (by concentration in lactate venous blood) in an exercise bicycle will be determined. On a second visit (4-7 days later), subjects will be randomly allocated to undergo either a 20-hour fasting session or a hyperinsulinemic, euglycemic clamp session. 10 volunteers will be assigned randomly to the fasting session for their first measurement and 10 will be assigned to the clamp session for their first measurement. The exercise session will be held before or after, but all volunteers must complete all three sessions.

In the fasting session, an intravenous line will be placed in the vein of an arm. After 30 minutes of rest and 12 hours of fasting, the gas exchange will be evaluated for 20 min by indirect calorimetry. During the measurement two blood samples (glucose, lactate, free fatty acids, triglycerides, VLDL, 3-OH-butyrate and insulin) will be extracted with an interval of 10 min between them. At the end of the calorimetric measurement the line will be removed, and the volunteer will remain at rest for 7 hours. At the end of the rest, an intravenous line will be installed and the calorimetric measurement will be performed for 20 min. During this period two blood samples (glucose, lactate, free fatty acids, triglycerides, VLDL, 3-OH-butyrate and insulin) will be extracted with an interval of 10 min between them.

In the euglycemic-hyperinsulinemic clamp session, individuals will attend under nighttime fasting conditions. An intravenous line will be installed in both arms. After 30 minutes of absolute rest and 12 hours of fasting, the gas exchange will be evaluated for 20 min by indirect calorimetry. During the measur
Primary Outcome(s)

1. Resting metabolic rate and respiratory quotient, measured by indirect calorimetry at two of three sessions with an interval of 4-7 days during the month following the selection
2. Glucose metabolic flexibility, measured by euglycemic-hyperinsulinemic clamp
3. Maximal aerobic capacity, measured by indirect calorimetry and a blood sample for lactate concentration in venous blood during exercise for 15 minutes. This measurement is performed during the month following the selection
Secondary Outcome(s)

1. Glucose, lactate, free fatty acids, triglycerides, VLDL, 3-OH-butyrate and insulin concentration, measured by taking two blood samples with a 10-minute interval before and after the clamp
2. Body mass and body composition, measured using the body mass index formula (BMI) and electrical bioimpedance
Secondary ID(s)
1170117
Source(s) of Monetary Support
Pontificia Universidad Católica de Chile (Santiago)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics Board at Pontificia Universidad Católica de Chile, 08/06/2017, ref: 1170117
Results
Results available: Yes
Date Posted:
Date Completed: 08/01/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history